Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yuan Zheng, Bu-Yu Zhou, Jing Wei, Yi Xu, Jian-Hua Dong, Lu-Yuan Guan, Ping Ma, Peng-Bo Yu & Jing-Jun Wang. (2018) Persistence of immune responses to vaccine against haemorrhagic fever with renal syndrome in healthy adults aged 16–60 years: results from an open-label2-year follow-up study. Infectious Diseases 50:1, pages 21-26.
Read now
Read now
Francisca Valdivieso, Claudia Gonzalez, Manuel Najera, Andrea Olea, Analia Cuiza, Ximena Aguilera & Gregory Mertz. (2017) Knowledge, attitudes, and practices regarding hantavirus disease and acceptance of a vaccine trial in rural communities of southern Chile. Human Vaccines & Immunotherapeutics 13:4, pages 808-815.
Read now
Read now
Articles from other publishers (35)
Ayushi Sehgal, Sanya Mehta, Kritika Sahay, Ekaterina Martynova, Albert Rizvanov, Manoj Baranwal, Sara Chandy, Svetlana Khaiboullina, Emmanuel Kabwe & Yuriy Davidyuk. (2023) Hemorrhagic Fever with Renal Syndrome in Asia: History, Pathogenesis, Diagnosis, Treatment, and Prevention. Viruses 15:2, pages 561.
Crossref
Crossref
Sheema Mir. (2022) Hantavirus Induced Kidney Disease. Frontiers in Medicine 8.
Crossref
Crossref
Kamil Leis, Patryk Kaczor, Aleksandra Baska, Jakub Kazik, Michalina Kolan, Katarzyna Grudlewska-Buda, Natalia Wiktorczyk & Krzysztof Skowron. (2021) Orthohantavirus Spp. – Review Of Genus. Postępy Mikrobiologii - Advancements of Microbiology 60:1, pages 91-102.
Crossref
Crossref
Yan Ma, Kang Tang, Yusi Zhang, Chunmei Zhang, Yun Zhang, Boquan Jin & Ying Ma. (2020) Design and synthesis of HLA-A*02-restricted Hantaan virus multiple-antigenic peptide for CD8+ T cells. Virology Journal 17:1.
Crossref
Crossref
Ying Ma, Kang Tang, Yusi Zhang, Chunmei Zhang, Linfeng Cheng, Fanglin Zhang, Ran Zhuang, Boquan Jin & Yun Zhang. (2020) Protective CD8+ T-cell response against Hantaan virus infection induced by immunization with designed linear multi-epitope peptides in HLA-A2.1/Kb transgenic mice. Virology Journal 17:1.
Crossref
Crossref
Kalpa Dheerasekara, Saranga Sumathipala & Rohitha Muthugala. (2020) Hantavirus Infections—Treatment and Prevention. Current Treatment Options in Infectious Diseases 12:4, pages 410-421.
Crossref
Crossref
Rongrong Liu, Hongwei Ma, Jiayi Shu, Qiang Zhang, Mingwei Han, Ziyu Liu, Xia Jin, Fanglin Zhang & Xingan Wu. (2020) Vaccines and Therapeutics Against Hantaviruses. Frontiers in Microbiology 10.
Crossref
Crossref
A. A. Sinyugina, A. A. Ishmukhametov, Т. К. Dzagurova, М. V. Balovneva, М. S. Egorova, S. S. Kurashova, N. A. Korotina, O. A. Leonovich, A. S. Balkina & Е. A. Tkachenko. (2019) Vaccines for Prevention of Hantaviral Fevers. Epidemiology and Vaccinal Prevention 18:5, pages 98-108.
Crossref
Crossref
Salas-Rojas Mónica, Gálvez-Romero Guillermo & Pompa-Mera Ericka Nelly. 2019. Vaccines - the History and Future. Vaccines - the History and Future.
Jong-Myon Bae. (2019) Introduction of Vaccinomics to Develop Personalized Vaccines in Light of Changes in the Usage of Hantaan Virus Vaccine (Hantavax®) in Korea. Journal of Preventive Medicine and Public Health 52:5, pages 277-280.
Crossref
Crossref
Bryce M Warner, Derek R Stein, Rohit K Jangra, Megan M Slough, Patrycja Sroga, Angela Sloan, Kathy L Frost, Stephanie Booth, Kartik Chandran & David Safronetz. (2019) Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses. Viruses 11:7, pages 645.
Crossref
Crossref
Rebecca L. Brocato & Jay W. Hooper. (2019) Progress on the Prevention and Treatment of Hantavirus Disease. Viruses 11:7, pages 610.
Crossref
Crossref
Daniel Oscar Alonso, Ayelen Iglesias, Rocio Coelho, Natalia Periolo, Agostina Bruno, Maria Teresa Córdoba, Noemi Filomarino, Marcelo Quipildor, Emiliano Biondo, Eduardo Fortunato, Carla Bellomo & Valeria Paula Martínez. (2019) Epidemiological description, case‐fatality rate, and trends of Hantavirus Pulmonary Syndrome: 9 years of surveillance in Argentina. Journal of Medical Virology 91:7, pages 1173-1181.
Crossref
Crossref
Matthew J. Simons, Elena E. Gorbunova & Erich R. Mackow. (2019) Unique Interferon Pathway Regulation by the Andes Virus Nucleocapsid Protein Is Conferred by Phosphorylation of Serine 386. Journal of Virology 93:10.
Crossref
Crossref
Yuhang Dong, Tiejun Ma, Xiaoxiao Zhang, Qikang Ying, Mingwei Han, Muqi Zhang, Rongjin Yang, Yuan Li, Fang Wang, Rongrong Liu & Xingan Wu. (2019) Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection. Journal of Medical Microbiology 68:3, pages 480-492.
Crossref
Crossref
Bryce Warner, Derek Stein, Bryan Griffin, Kevin Tierney, Anders Leung, Angela Sloan, Darwyn Kobasa, Guillaume Poliquin, Gary Kobinger & David Safronetz. (2019) Development and Characterization of a Sin Nombre Virus Transmission Model in Peromyscus maniculatus. Viruses 11:2, pages 183.
Crossref
Crossref
Silvia Ratto-Kim, In-Kyu Yoon, Robert M. Paris, Jean-Louis Excler, Jerome H. Kim & Robert J. O’Connell. (2018) The US Military Commitment to Vaccine Development: A Century of Successes and Challenges. Frontiers in Immunology 9.
Crossref
Crossref
Dong-Bo Jiang, Jin-Peng Zhang, Lin-Feng Cheng, Guan-Wen Zhang, Yun Li, Zi-Chao Li, Zhen-Hua Lu, Zi-Xin Zhang, Yu-Chen Lu, Lian-He Zheng, Fang-Lin Zhang & Kun Yang. (2018) Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy. Antiviral Research 150, pages 174-182.
Crossref
Crossref
Dong-Bo Jiang, Li-Juan Sun, Lin-Feng Cheng, Jin-Peng Zhang, Shao-Bo Xiao, Yuan-Jie Sun, Shu-Ya Yang, Jing Wang, Fang-Lin Zhang & Kun Yang. (2017) Recombinant DNA vaccine of Hantavirus Gn and LAMP1 induced long-term immune protection in mice. Antiviral Research 138, pages 32-39.
Crossref
Crossref
Ki Ho Hong. (2017) Viral Infections in Workers in Hospital and Research Laboratory Settings. Annals of Clinical Microbiology 20:2, pages 27.
Crossref
Crossref
Lyle R. Petersen & Thomas G. Ksiazek. 2017. Infectious Diseases. Infectious Diseases
1493
1508.e2
.
Gonzalo P. Barriga, Fernando Villalón-Letelier, Chantal L. Márquez, Eduardo A. Bignon, Rodrigo Acuña, Breyan H. Ross, Octavio Monasterio, Gonzalo A. Mardones, Simon E. Vidal & Nicole D. Tischler. (2016) Inhibition of the Hantavirus Fusion Process by Predicted Domain III and Stem Peptides from Glycoprotein Gc. PLOS Neglected Tropical Diseases 10:7, pages e0004799.
Crossref
Crossref
Salwa Mohd Mostafa & Abul BMMK Islam. (2016)
An
in silico
approach predicted potential therapeutics that can confer protection from maximum pathogenic Hantaviruses
. Future Virology 11:6, pages 411-428.
Crossref
Crossref
Lu-Xi Zou, Mao-Jie Chen & Ling Sun. (2016) Haemorrhagic fever with renal syndrome: literature review and distribution analysis in China. International Journal of Infectious Diseases 43, pages 95-100.
Crossref
Crossref
P. Guillaume Poliquin, Michael Drebot, Allen Grolla, Shane E. Jones, Bryce Larke & James E. Strong. (2015) Therapeutic Approaches for New World Hantaviruses. Current Treatment Options in Infectious Diseases 7:3, pages 230-239.
Crossref
Crossref
Bryan Thoma, Jörg Müller, Claus Bässler, Enrico Georgi, Anja Osterberg, Susanne Schex, Christian Bottomley & Sandra Essbauer. (2014) Identification of FactorsInfluencing the Puumala Virus Seroprevalence within Its Reservoir in aMontane Forest Environment. Viruses 6:10, pages 3944-3967.
Crossref
Crossref
Changjun Bao, Wanwan Liu, Yefei Zhu, Wendong Liu, Jianli Hu, Qi Liang, Yuejia Cheng, Ying Wu, Rongbin Yu, Minghao Zhou, Hongbing Shen, Feng Chen, Fenyang Tang & Zhihang Peng. (2014) The Spatial Analysis on Hemorrhagic Fever with Renal Syndrome in Jiangsu Province, China Based on Geographic Information System. PLoS ONE 9:9, pages e83848.
Crossref
Crossref
Tatjana Avšič Županc, Miša Korva & Alemka Markotić. (2014) HFRS and hantaviruses in the Balkans/South-East Europe. Virus Research 187, pages 27-33.
Crossref
Crossref
Yuichi AOYAMA, Shinsuke OHTA, Saburou SAKAKI & Shigeru NISHIZAWA. (2014) The Pitfall in Conservative Therapy for Working Patients with Brain Ischemia就労中の頭蓋内血管狭窄患者に対する保存的治療における盲点. Journal of UOEH 36:1, pages 33-39.
Crossref
Crossref
Aurelija Zvirbliene, Indre Kucinskaite-Kodze, Ausra Razanskiene, Rasa Petraityte-Burneikiene, Boris Klempa, Rainer Ulrich & Alma Gedvilaite. (2014) The Use of Chimeric Virus-like Particles Harbouring a Segment of Hantavirus Gc Glycoprotein to Generate a Broadly-Reactive Hantavirus-Specific Monoclonal Antibody. Viruses 6:2, pages 640-660.
Crossref
Crossref
Tatjana Avšič Županc & Miša Korva. 2014. Emerging Infectious Diseases. Emerging Infectious Diseases
25
36
.
Evgeniy A. Tkachenko, Tamara K. Dzagurova & Peter E. Tkachenko. 2014. Novel Technologies for Vaccine Development. Novel Technologies for Vaccine Development
113
151
.
David Safronetz, Darryl Falzarano, Dana P. Scott, Yousuke Furuta, Heinz Feldmann & Brian B. Gowen. (2013) Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome. Antimicrobial Agents and Chemotherapy 57:10, pages 4673-4680.
Crossref
Crossref
Darryl Falzarano & Heinz Feldmann. (2013) Vaccines for viral hemorrhagic fevers—progress and shortcomings. Current Opinion in Virology 3:3, pages 343-351.
Crossref
Crossref
James Hartline, Chris Mierek, Tristan Knutson & Christopher Kang. (2013) Hantavirus infection in North America: a clinical review. The American Journal of Emergency Medicine 31:6, pages 978-982.
Crossref
Crossref